FISCHETTI, Carmela
 Distribuzione geografica
Continente #
NA - Nord America 698
EU - Europa 311
AS - Asia 103
SA - Sud America 1
Totale 1.113
Nazione #
US - Stati Uniti d'America 692
PL - Polonia 136
CN - Cina 72
UA - Ucraina 45
GB - Regno Unito 42
DE - Germania 36
IT - Italia 33
TR - Turchia 26
FI - Finlandia 9
BE - Belgio 6
CA - Canada 6
SE - Svezia 3
VN - Vietnam 2
EC - Ecuador 1
FR - Francia 1
ID - Indonesia 1
KR - Corea 1
NP - Nepal 1
Totale 1.113
Città #
Warsaw 136
Fairfield 84
Woodbridge 78
Ann Arbor 73
Houston 57
Jacksonville 48
Chandler 43
Ashburn 40
Seattle 34
Wilmington 31
Cambridge 27
Beijing 21
New York 21
Izmir 16
Milan 16
Princeton 12
Falls Church 11
Munich 11
Nanjing 11
San Diego 11
Shanghai 10
Boardman 9
Mcallen 9
Brussels 6
Auburn Hills 5
Montréal 5
Bremen 4
Cagliari 4
Changsha 4
Dearborn 4
Hebei 4
Jinan 4
Nanchang 4
San Mateo 4
Shenyang 4
Norwalk 3
Philadelphia 3
Addison 2
Dong Ket 2
Ferrara 2
Fuzhou 2
Hounslow 2
Montechiarugolo 2
Mountain View 2
Taizhou 2
Tappahannock 2
Tianjin 2
Zhengzhou 2
Collecorvino 1
Colleferro 1
Council Bluffs 1
Des Moines 1
Hendon 1
Indiana 1
Kunming 1
La Canada Flintridge 1
Leawood 1
Leicester 1
Loja 1
London 1
Los Angeles 1
New Bedfont 1
Ningbo 1
Orange 1
Padova 1
Redwood City 1
San Francisco 1
Sanwal 1
Toronto 1
Wandsworth 1
Totale 911
Nome #
NOCICEPTIN/ORPHANIN FQ RECEPTOR LIGANDS: PHARMACOLOGICAL STUDIES 175
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 142
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 123
Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic G i/o protein linked pathways 115
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 111
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 100
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 93
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 91
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. 88
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 84
Totale 1.122
Categoria #
all - tutte 3.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 0 0 0 32 56
2019/2020292 37 13 11 32 20 27 23 31 23 30 30 15
2020/2021160 15 18 12 19 12 19 7 18 3 20 11 6
2021/2022136 8 14 13 10 7 8 11 5 3 12 10 35
2022/2023126 14 1 7 11 24 14 11 15 19 0 4 6
2023/202470 5 9 2 1 3 26 6 9 5 1 3 0
Totale 1.122